More recently, evidence of NOTCH1 mutationsin 25%-50% of pediatric T-ALL patients has furtherenhanced the biologic heterogeneity of T-ALL [10,11]. The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.